Blue Water Biotech Inc.

📍 Cincinnati, United States🗓 Founded 2018👥 3 employees💰 Last funded 2019
Biotechnology Research🌐 bwbioinc.com
Website LinkedIn
Blue Water Biotech Inc. (Nasdaq: BWV) is a biopharmaceutical company focused on developing transformational therapies to address significant health challenges globally. The company holds the rights to proprietary technology developed at the University of Oxford, Cincinnati Childrens Hospital Medical Center (CCHMC), and St. Jude Childrens Hospital. The company is developing a universal flu vaccine that will provide protection from all virulent strains in addition to licensing a novel norovirus (NoV) S&P nanoparticle versatile virus-like particle (VLP) vaccine platform from CCHMC to develop vaccines for multiple infectious diseases, including norovirus/rotavirus and malaria, among others. Additionally, Blue Water Vaccines is developing a Streptococcus pneumoniae (pneumococcus) vaccine candidate, designed to specifically prevent the highly infectious middle ear infections, known as Acute Otitis Media (AOM), in children.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Blue Water Biotech Inc.?
Blue Water Biotech Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Blue Water Biotech Inc. last raise funding?
The most recent investment in Blue Water Biotech Inc. recorded on gritt.io was in 2019.
When was Blue Water Biotech Inc. founded?
Blue Water Biotech Inc. was founded in 2018.
What industry is Blue Water Biotech Inc. in?
Blue Water Biotech Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Blue Water Biotech Inc. based?
Blue Water Biotech Inc. is headquartered in Cincinnati, United States.